-transparent.png){kind=logo}
7,N,N-Trimethyltryptamine (TMT) was synthesized and evaluated as an inhibitor of synaptosomal biogenic amine uptake in rat forebrain homogenates. In addition to inhibiting 3H-serotonin uptake (IC50 = 0.4 micrometer), TMT appears to be quite selective and is much less potent in blocking either 3H-norepinephrine or 3H-dopamine uptake (IC50 = 180 micrometer and 61 micrometer, respectively).
Related Publications
R A Glennon, and
B Martin, and
K M Johnson, and
D End
April 1978,
Clinical pharmacology and therapeutics,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
January 1991,
Medicinal research reviews,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
September 1992,
Ceskoslovenska psychiatrie,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
January 1990,
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
August 1974,
Life sciences,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
September 1993,
The Nurse practitioner,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
October 1988,
Research communications in chemical pathology and pharmacology,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
November 2010,
Biochemical pharmacology,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
March 1981,
European journal of pharmacology,
R A Glennon, and
B Martin, and
K M Johnson, and
D End
January 1988,
Journal of medicinal chemistry,
